Strategic Acquisition Accelerates Nipro Diagnostics Vision to be a Total Diabetes Healthcare Supplier.

Thursday, 1st August 2013


P.J. Noyes Will Significantly Expand High-Quality, High-Value Diabetes Management Products Manufacturing Capability.


(Fort Lauderdale, FL) – Nipro Diagnostics, Inc. – a leading manufacturer and marketer of blood glucose monitoring products and diabetes management supplies – today announced the acquisition of P.J. Noyes, a privately held New Hampshire-based manufacturer of OTC healthcare, personal care products, nutraceuticals, and dietary supplements.

“This strategic acquisition expands Nipro Diagnostics’ capabilities, adds expertise, pipeline of formulations and expands our USA-based manufacturing. Our leadership position in blood glucose monitoring is the foundation of our ecosystem, including sharps, nutraceuticals, personal care products and dietary supplements. We are committed to supporting the health and wellness needs of an ever-growing diabetes population with high-quality, low-cost products,” said Scott Verner, President and CEO of Nipro Diagnostics.

Its unique combination of product development, manufacturing and packaging expertise aligns perfectly with our goals for portfolio expansion

P.J. Noyes’ expertise complements Nipro Diagnostics’ state-of-the-art capabilities as a leading manufacturer of blood glucose monitors, strips and accessories. The acquisition provides vertical integration and enables significant expansion into a more comprehensive diabetes management product portfolio. New product opportunities will fit well into Nipro Diagnostics’ co-brand marketing strategy. Today, retailers, distributors and mail service providers trust Nipro Diagnostics as their exclusive, co-brand blood glucose monitoring system partner. Nipro Diagnostics’ TRUE brand of products represents the highest in quality and value with proven performance that is equal or superior to competitive brands, at significantly lower costs. The same value equation will be true of new diabetic products manufactured by P.J. Noyes.

Nipro Diagnostics’ vision is to maintain its current value proposition over its entire product portfolio and to develop a diabetes management solution that offers innovative, affordable solutions for diabetes patients to lead healthier lives. Patients with diabetes experience multiple co-morbidities such as foot and skin care issues, nutritional and weight management concerns, neuropathy, and eye care problems. Satisfying these needs enables Nipro Diagnostics to extend its current model into a market basket strategy, with a focus on helping retailers to leverage their own brand success and maximize value per patient.

Nipro Diagnostics has already begun expanding its product portfolio to high-quality, low-cost accessory products including syringes, lancets, ketone strips, glucose shots, tablets and gels under its TRUEplus brand. The acquired capabilities of P.J. Noyes accelerates this new product development strategy and will quickly and significantly expand Nipro Diagnostics’ diabetes management products portfolio.

Nipro Diagnostics’ strategic acquisition of P.J. Noyes is the first step towards achieving its strategic vision as a comprehensive, single-source total diabetes healthcare supplier that will deliver significant profitability and ability for its business partners to create a diabetes destination that will afford unprecedented quality and value to diabetic consumers.

Verner concluded, “We are excited to see our vision unfold and remain committed to a strategy of portfolio expansion, high-performance, high-value products, and partner profitability – all of which will allow us to realize our vision as a leading total diabetes healthcare supplier.”

About Nipro Corporation

Nipro Corporation, headquartered in Osaka, Japan, has been a world leader in providing medical products to the healthcare community for over 50 years. In addition to Nipro branded products, Nipro provides manufacturing support to some of the biggest names in the medical field.

About Nipro Diagnostics, Inc

Based in Fort Lauderdale, Florida, Nipro Diagnostics, Inc. is a leading developer, manufacturer and marketer of diabetes monitoring and management products. The company offers a portfolio of high- quality blood glucose monitoring systems and diabetes management products available around the world. Nipro Diagnostics is the exclusive supplier of blood glucose monitoring systems, co-branded under the TRUE name, to the world’s leading pharmacies, distributors and mail service providers. For more information, please visit: www.niprodiagnostics.com

About P.J. Noyes Company

Based in Lancaster, New Hampshire, P.J. Noyes Company is dedicated to serving its contract-manufacturing customers in the markets of dietary supplements, OTC nutraceuticals, personal care products, homeopathics, and dietary products. These customers range in size from sole proprietorships to multinational corporations. Products made at P. J. Noyes Company are found in all major U.S. retail outlets and on many shelves around the world. For more information, please visit: www.pjnoyes.com.

Click here for the press release